• FGF23 is a biomarker for osteoporosis and cardiovascular calcification.
• Calibrated: The glycosylated human FGF23 (25-251) recombinant

Citations:

• Anne-Sophie Bargnoux et al. "Biomarkers of vascular calcifications: what are analytical limits to apply “research-grade” diagnostic kits into daily practice?" doi: 10.1684/abc.2015.1043.
• Muhammed Kizilgu, et al. "Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?" Arch Endocrinol Metab. 2017 Dec;61(6):562-566. doi: 10.1590/2359-3997000000287